Array BioPharma Inc. (ARRY Quick QuoteARRY - Free Report) was a big mover last session, as its shares rose over 9% on the day. The upside was driven by the company’s revenue beat in the fourth quarter of fiscal 2016. This led to far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $3.53 to $4.22 in the past one-month time frame.

None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Array BioPharma currently carries a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

ARRAY BIOPHARMA Price

ARRAY BIOPHARMA Price | ARRAY BIOPHARMA Quote

A better-ranked stock in the med-biomed/gene space is Anika Therapeutics Inc. (ANIK Quick QuoteANIK - Free Report) , which sports a Zacks Rank #1 (Strong Buy).

Is ARRY going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>